. . . " "@en . . . "Hexamethonium"@en . "U.S. Patent 2,641,610."@en . "# Adams DJ, Bevan S, Terrar DA: Modes of hexamethonium action on acetylcholine receptor channels in frog skeletal muscle. Br J Pharmacol. 1991 Jan;102(1):135-45. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/1710523"@en . . . . . . . . . "experimental"@en . . . "60-26-4"@en . . "N,N,N,N',N',N'-hexamethylhexane-1,6-diaminium"@en . . . . . . . . . . "A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool."@en . . . . .